Mohit Manrao
@mohitmanrao
Followers
75
Following
30
Statuses
161
RT @AstraZeneca: The #ACatalystNetwork is seeking partners — from healthcare professionals, academia, policy makers to entrepreneurs — to d…
0
6
0
RT @AstraZeneca: We are developing antibody drug conjugates (ADCs) to treat a range of tumour types, including breast, lung, and gastric ca…
0
22
0
RT @AstraZeneca: When treating #lungcancer, every minute counts. By mobilising a multidisciplinary team of experts early in the treatment p…
0
7
0
RT @IASLC: #WCLC20 @giorgioscaglio3 presents the mission to double the cancer cure rate by 2025 and how to do it.
0
6
0
RT @AstraZeneca: Together with @globalungcancer @IASLC @GuardantHealth as part of the #LungAmbition Alliance our goal is to accelerate prog…
0
6
0
RT @AstraZeneca: Calling all #lungcancer organisations: does your idea have the power to transform the lives of patients? We want to make i…
0
4
0
RT @AstraZeneca: Examining our assumptions of others is vital to making systemic change. Nearly 80% of people believe #lungcancer is caused…
0
4
0
RT @AstraZeneca: Delays in #lungcancer diagnosis and treatment must be addressed to improve patient outcomes. The #LungAmbition Alliance ai…
0
4
0
RT @AstraZeneca: We’re pleased to present 84 abstracts from our #cancer research at #AACR19 this week. Our data will highlight the explorat…
0
7
0
RT @AstraZeneca: Cambridge (UK) is where our global HQ is, and one of our main Science Centers. We proudly sponsor the Cambridge Science Fe…
0
8
0
RT @ouse_akira: 明日はいよいよ #AGデビューコンテスト ライヴ１日目！ 開演19:30～。出番は20:15～。 応援してくれる皆の思いを胸に歌うよ。 ご予約はこちらから♥→ この写真が和泉家座談会で言ってたマウン…
0
68
0
RT @Japan_kenpou: 論説 日本国憲法 戦争なんか放棄していない日本国憲法第9条『よく読むと怖い日本国憲法第9条』 #narou #narouN1535DN 日本国憲法第9条は、戦争放棄していません。 #日本国憲…
0
4K
0
RT @AstraZenecaUS: Fighting cancer using the body’s own immune system? It’s called #ImmunoOnc. #CancerImmunotherapyMonth
0
8
0
RT @AstraZeneca: We'll be presenting 73 abstracts at #ASCO16, a third of which will focus on #DNA damage response
0
37
0
RT @AstraZeneca: Early detection of #LungCancer + testing at progression is paramount to optimal treatment #ELCC16
0
23
0